150 related articles for article (PubMed ID: 1863078)
21. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
22. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
23. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
24. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
26. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
[TBL] [Abstract][Full Text] [Related]
27. Skin cancer of the head--treatment by radiotherapy.
Fitzpatrick PJ
J Otolaryngol; 1984 Aug; 13(4):261-6. PubMed ID: 6433042
[TBL] [Abstract][Full Text] [Related]
28. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
Demers AA; Nugent Z; Mihalcioiu C; Wiseman MC; Kliewer EV
J Am Acad Dermatol; 2005 Aug; 53(2):320-8. PubMed ID: 16021129
[TBL] [Abstract][Full Text] [Related]
29. Mortality risk from squamous cell skin cancer.
Clayman GL; Lee JJ; Holsinger FC; Zhou X; Duvic M; El-Naggar AK; Prieto VG; Altamirano E; Tucker SL; Strom SS; Kripke ML; Lippman SM
J Clin Oncol; 2005 Feb; 23(4):759-65. PubMed ID: 15681519
[TBL] [Abstract][Full Text] [Related]
30. Analysis of 15 years of skin cancer in central Iran (Yazd).
Noorbala MT; Kafaie P
Dermatol Online J; 2007 Oct; 13(4):1. PubMed ID: 18318998
[TBL] [Abstract][Full Text] [Related]
31. [Survival after cutaneous metastasis: a study of 200 cases].
Schoenlaub P; Sarraux A; Grosshans E; Heid E; Cribier B
Ann Dermatol Venereol; 2001 Dec; 128(12):1310-5. PubMed ID: 11908133
[TBL] [Abstract][Full Text] [Related]
32. Lip cancer experience in Mexico. An 11-year retrospective study.
Luna-Ortiz K; Güemes-Meza A; Villavicencio-Valencia V; Mosqueda-Taylor A
Oral Oncol; 2004 Nov; 40(10):992-9. PubMed ID: 15509490
[TBL] [Abstract][Full Text] [Related]
33. Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968-99.
Stang A; Jöckel KH
Br J Dermatol; 2004 Mar; 150(3):517-22. PubMed ID: 15030336
[TBL] [Abstract][Full Text] [Related]
34. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort.
Lindelöf B; Jarnvik J; Ternesten-Bratel A; Granath F; Hedblad MA
Acta Derm Venereol; 2006; 86(3):219-22. PubMed ID: 16710578
[TBL] [Abstract][Full Text] [Related]
35. Nonmelanoma skin cancer. Risks, treatment options, and tips on prevention.
Kibarian MA; Hruza GJ
Postgrad Med; 1995 Dec; 98(6):39-40, 45-8, 55-6 passim. PubMed ID: 7501580
[TBL] [Abstract][Full Text] [Related]
36. Craniofacial surgery for nonmelanoma skin malignancy: report of an international collaborative study.
Maghami EG; Talbot SG; Patel SG; Singh B; Polluri A; Bridger PG; Cantu G; Cheesman AD; De Sa G; Donald P; dos Santos LR; Fliss D; Gullane P; Janecka I; Kamata SE; Kowalski LP; Kraus DH; Levine PA; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
Head Neck; 2007 Dec; 29(12):1136-43. PubMed ID: 17764086
[TBL] [Abstract][Full Text] [Related]
37. Validity of patient self-reported history of skin cancer.
Ming ME; Levy RM; Hoffstad OJ; Filip J; Gimotty PA; Margolis DJ
Arch Dermatol; 2004 Jun; 140(6):730-5. PubMed ID: 15210466
[TBL] [Abstract][Full Text] [Related]
38. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
Healy E; Collins P; Barnes L
Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
[TBL] [Abstract][Full Text] [Related]
39. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
40. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
